Pages that link to "Q47305302"
Jump to navigation
Jump to search
The following pages link to Activation of the Aryl Hydrocarbon Receptor Leads to Resistance to EGFR TKIs in Non-Small-Cell Lung Cancer by Activating Src-Mediated Bypass Signaling (Q47305302):
Displaying 11 items.
- Signaling Events Downstream of AHR Activation That Contribute to Toxic Responses: The Functional Role of an AHR-Dependent Long Noncoding RNA ( slincR) Using the Zebrafish Model (Q58551190) (← links)
- The Aryl Hydrocarbon Receptor and the Maintenance of Lung Health (Q60915889) (← links)
- Tryptophan metabolites kynurenine and serotonin regulate fibroblast activation and fibrosis (Q90355553) (← links)
- The therapeutic potential of targeting tryptophan catabolism in cancer (Q91826310) (← links)
- Constitutive Aryl Hydrocarbon Receptor Signaling in Prostate Cancer Progression (Q92060725) (← links)
- Combined treatment with N-acetylcysteine and gefitinib overcomes drug resistance to gefitinib in NSCLC cell line (Q92348262) (← links)
- AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs) (Q92348444) (← links)
- The deubiquitylase UCHL3 maintains cancer stem-like properties by stabilizing the aryl hydrocarbon receptor (Q96431846) (← links)
- Cancer cells undergoing epigenetic transition show short-term resistance and are transformed into cells with medium-term resistance by drug treatment (Q97530450) (← links)
- Aryl hydrocarbon receptor mediates Jak2/STAT3 signaling for non-small cell lung cancer stem cell maintenance (Q99561943) (← links)
- EGFR inhibition triggers an adaptive response by co-opting antiviral signaling pathways in lung cancer (Q103837483) (← links)